This notion is further supported by the observation that MYC-induced B-cell lymphomas dramatically reduced the time of latency at either a DMTF1(−/−) or DMTF1(+/−) genetic background. The gene discussed is DMTF1; the disease is B-cell non-Hodgkin lymphoma.